
Sign up to save your podcasts
Or
Send us a text
This comprehensive overview introduces Marty Emanuele, PhD, MBA, highlighting his scientific background and journey into the field of gene therapy. The discussion explores the development and impact of a groundbreaking gene therapy designed to combat specific health issues, addressing differences between fatty acids, contributing factors to disease burden, and the role of seed oils as metabolic disruptors. Additionally, the conversation delves into the rise of diseases in Western society, the implications of prescription drug expenses, and the accessibility of this innovative treatment. Marty emphasizes that the simplest actions often yield the most significant health benefits.
Marty Emanuele, PhD, MBA, is the Co-Founder and Chief Scientific Officer of Visgenx, Inc., with over 35 years of experience in the Pharma and Biotech industries. With a career spanning senior executive management, research and development, and corporate business development, Marty has been instrumental in leading R&D teams to achieve significant milestones, including four original INDs and participation in two successful NDAs. He is an inventor on 11 U.S. patents and has served as a primary investigator on grants awarded by the NIH and FDA. Marty's leadership extends to global collaborations with major pharmaceutical companies such as Merck, AstraZeneca, and Novartis, resulting in out-license and partnership transactions valued at over $1 billion. As a Co-Founder of multiple companies, including CytRx Corp, SynthRx, Inc., and LifeRaft Inc., Marty also conceived and implemented the DaVita BioBank, the world's largest commercial biorepository at the time.
https://visgenx.com/
Are you eager to explore more about health and wellness? Discover an all natural solution to combating the GLP-1 Receptor Agonist craze. Click on the link below and explore the Feel Great System - a clinically proven approach to boosting natural GLP-1 production, suppressing appetite and improving both your metabolism and weight.
https://ufeelgreat.com/usa/en/c/LiveFree
As a Decoding Health viewer, you get wholesale pricing and a money back guarantee. Give it a try and let us know your results.
https://imbiopharma.com/
https://www.linkedin.com/in/urban-a-kiernan-ph-d-8568b621/
https://www.youtube.com/@DecodingHealthPodcast
Thank you to our sponsor - iMetabolic Biopharma Corporation: Together, we can be the next stage in developing a revolutionary approach to drug discovery. We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable. Visit https://imbiopharma.com/ to learn more.
5
22 ratings
Send us a text
This comprehensive overview introduces Marty Emanuele, PhD, MBA, highlighting his scientific background and journey into the field of gene therapy. The discussion explores the development and impact of a groundbreaking gene therapy designed to combat specific health issues, addressing differences between fatty acids, contributing factors to disease burden, and the role of seed oils as metabolic disruptors. Additionally, the conversation delves into the rise of diseases in Western society, the implications of prescription drug expenses, and the accessibility of this innovative treatment. Marty emphasizes that the simplest actions often yield the most significant health benefits.
Marty Emanuele, PhD, MBA, is the Co-Founder and Chief Scientific Officer of Visgenx, Inc., with over 35 years of experience in the Pharma and Biotech industries. With a career spanning senior executive management, research and development, and corporate business development, Marty has been instrumental in leading R&D teams to achieve significant milestones, including four original INDs and participation in two successful NDAs. He is an inventor on 11 U.S. patents and has served as a primary investigator on grants awarded by the NIH and FDA. Marty's leadership extends to global collaborations with major pharmaceutical companies such as Merck, AstraZeneca, and Novartis, resulting in out-license and partnership transactions valued at over $1 billion. As a Co-Founder of multiple companies, including CytRx Corp, SynthRx, Inc., and LifeRaft Inc., Marty also conceived and implemented the DaVita BioBank, the world's largest commercial biorepository at the time.
https://visgenx.com/
Are you eager to explore more about health and wellness? Discover an all natural solution to combating the GLP-1 Receptor Agonist craze. Click on the link below and explore the Feel Great System - a clinically proven approach to boosting natural GLP-1 production, suppressing appetite and improving both your metabolism and weight.
https://ufeelgreat.com/usa/en/c/LiveFree
As a Decoding Health viewer, you get wholesale pricing and a money back guarantee. Give it a try and let us know your results.
https://imbiopharma.com/
https://www.linkedin.com/in/urban-a-kiernan-ph-d-8568b621/
https://www.youtube.com/@DecodingHealthPodcast
Thank you to our sponsor - iMetabolic Biopharma Corporation: Together, we can be the next stage in developing a revolutionary approach to drug discovery. We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable. Visit https://imbiopharma.com/ to learn more.
3,611 Listeners
7,222 Listeners
1,873 Listeners
9,262 Listeners
12,998 Listeners
285 Listeners
298 Listeners
1,655 Listeners
476 Listeners
86 Listeners
1,183 Listeners
3,087 Listeners
331 Listeners
27 Listeners
12 Listeners